Aquestive Therapeutics
Income Statement

Last updated:

Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. Aquestive Therapeutics's past years’ income statements indicate that its last revenue has increased compared to the previous period by 6% to $50,583,000. The net income raised on -$7,870,000 and profit margin reached -16%. Total operating expenses were $44,854,000.

Profit Margin

Aquestive Therapeutics, Inc. (NASDAQ:AQST): Profit margin
2016 51.78M -9.60M -18.54%
2017 66.91M -8.94M -13.36%
2018 67.43M -61.37M -91.02%
2019 52.60M -72.65M -138.11%
2020 45.84M -65.36M -142.56%
2021 50.83M -90.03M -177.12%
2022 47.68M -60.20M -126.26%
2023 50.58M -7.87M -15.56%

AQST Income Statement (2016 – 2023)

2023 2022 2021 2020 2019 2018 2017 2016
Revenue
Revenue
50.58M47.68M50.83M45.84M52.60M67.43M66.91M51.78M
Cost of revenue
20.83M19.38M14.98M12.96M20.36M20.98M19.82M16.37M
Gross profit
29.75M28.29M35.84M32.88M32.24M46.44M47.09M35.40M
Operating exp.
Research and development
13.10M17.48M17.04M19.88M20.57M23.11M22.13M15.45M
Selling and marketing
00000000
Total operating expenses
44.85M70.36M70.52M75.77M84.91M95.37M47.21M36.25M
Operating income
-15.10M-42.06M-34.67M-42.89M-52.66M-48.93M-113K-847K
Other income (expenses), net
7.47M-12.34M-35.86M-12.89M-13.57M-5.28M-8.83M-2.61M
Income before tax
-7.62M-54.41M-70.53M-55.78M-66.24M-61.37M-8.94M-9.60M
Income tax expense
245K5.79M19.49M9.57M6.41M-4.73M7.70M6.04M
Net income
-7.87M-60.20M-90.03M-65.36M-72.65M-61.37M-8.94M-9.60M
Earnings per share
Basic EPS
-0.13-1.24-2.36-1.94-2.87-2.96-0.45-0.39
Diluted EPS
-0.13-1.24-2.36-1.94-2.87-2.96-0.45-0.39
Data sourceData sourceData sourceData sourceData sourceData source